Three Technologies That Will Guide Revascularization of Chronic Coronary Syndrome Patients into the 21st Century: A Review
- Michael A. Winkler(corresponding author),
- Ripa Patel,
- Weibo Fu,
- ,
- ,
- Augusta University,
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOpen access
Abstract
Although medical therapy is the preferred first-line treatment for patients with chronic coronary syndrome (CCS), revascularization remains an important consideration. We present a review that identifies the three diagnostic technologies most important to guiding the decision to revascularize patients with CCS: (1) cardiac computed tomography, (2) intracoronary imaging, and (3) lesion-specific physiological guidance.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 212-220 (9 pages)Journal (Volume, Issue Number)
International Journal of Angiology (Volume 30, Issue 3)Publication milestones
- Published - 11/10/2021
Publication status
Published - 11/10/2021
ISSN
1061-1711Publication IDs
- Scopus: 85114103359
Publication metrics
Metrics
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
1
PlumX, opens in new tab
Captures
10
Funding Details
Dr. Winkler receives research support from Terarecon, Ziosoft, Algomedica, and Teleflex. Dr. Arora receives research support from Terarecon. Dr. Weintraub is funded by grants from the National Institutes of Health (HL142097, HL134354, R56AG064895, and AR070029).
FunderFunding numbers
NIH
HL134354, R56AG064895, HL142097, AR070029
